Ruffilli, Camilla https://orcid.org/0000-0001-7501-3744
Röth, Sascha https://orcid.org/0000-0001-7273-6701
Zelcer, Noam https://orcid.org/0000-0001-6935-7532
Moreau, Kevin https://orcid.org/0000-0002-3688-3998
Funding for this research was provided by:
European Union’s Horizon 2020 Research and Innovation (953489)
Article History
Received: 25 March 2024
Accepted: 20 December 2024
First Online: 2 January 2025
Declarations
:
: The authors declare the following competing financial interest(s): CR, SR and KM are employees of AstraZeneca. NZ has no competing interests to declare.